Bariatric Surgery Devices Market Size, Share, Growth, and Industry Analysis, By Type (Implantable Gastric simulators,Intragstric Balloons,Surgical Staples,Gastric Surgery Clamps,Trocars,Clip Appliers,Sutures,Surgical Clamps,Endo Stitch), By Application (Hospital,Clinic,Beauty Institution,Others), Regional Insights and Forecast to 2035

Bariatric Surgery Devices Market Overview

The global Bariatric Surgery Devices Market size is projected to grow from USD 2253.28 million in 2026 to USD 2340.93 million in 2027, reaching USD 3176.72 million by 2035, expanding at a CAGR of 3.89% during the forecast period.

The global bariatric surgery devices market research report indicates that in 2024 the market demonstrated strong expansion, driven by the rising prevalence of obesity and metabolic disorders, with more than 650 million adults classified as obese worldwide and obesity-related comorbidities increasing by over 10% annually. This Bariatric Surgery Devices Market Analysis and Bariatric Surgery Devices Industry Report highlight substantial growth potential in the devices segment, supported by increasing adoption of surgical weight-loss procedures. The Bariatric Surgery Devices Market Insights emphasize the critical role of these devices in managing metabolic diseases, improving patient outcomes, and addressing the growing global burden of obesity through advanced surgical interventions. Looking ahead, the market forecast in this market research report suggests that by 2034 the global market size will exceed USD 3,000 million, driven by over 25 million bariatric procedures globally in the 2024-2034 window.

The market opportunities stem from the increasing count of hospital facilities offering advanced bariatric surgery devices, rising end-user adoption in ambulatory surgical centres, and expanding geographic reach in Asia-Pacific and Latin America markets. This market trends analysis and market growth outlook emphasise that B2B manufacturers and suppliers can capture sizeable market share by aligning with hospital procurement strategies and clinic partnerships.

In the United States market analysis for bariatric surgery devices, the U.S. market size was evaluated at approximately USD 1,560 million in 2024 and is projected to reach around USD 2,680 million by 2034. With over 40 % of the global device consumption concentrated in the U.S. due to high obesity rates (over 42% of adults classified as obese) and more than 300,000 bariatric procedures performed annually, the country remains the dominant market in North America. The industry report indicates that the U.S. healthcare infrastructure supports an average of 1,500 specialised bariatric surgery centres, and the equipment spend per centre averages USD 0.5 million annually. The market outlook highlights opportunities for device makers targeting hospital systems, surgical centres, and outpatient clinics in the U.S., driven by demand for minimally invasive instruments, implantable gastric simulation devices, and endoscopic treatments.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Demand driven by obesity prevalence where approximately 46% of patients undergo bariatric procedures in regions reporting 30 %+ metabolic syndrome incidence.
• Major Market Restraint: High initial device cost burden impacts adoption in roughly 28% of smaller clinics and ambulatory surgical centres.
• Emerging Trends: Minimally invasive and non-invasive bariatric surgery devices account for nearly 45% of new product launches and protocol shifts.
• Regional Leadership: North America commands around 42% of the global bariatric surgery devices market share, with Asia-Pacific rapidly gaining momentum.
• Competitive Landscape: Top five manufacturers hold approximately 65% of global market share, pointing to moderate consolidation in the bariatric surgery devices industry.
• Market Segmentation: Implantable devices capture about 35% of device-type revenue while accessory instruments represent approximately 55% of procedure-related volumes.
• Recent Development: New endoscopic sleeve gastroplasty platforms now account for about 18% of total bariatric device shipments in the past 12 months.

Bariatric Surgery Devices Market Trends

In the market trends for bariatric surgery devices market research report, we observe that the device industry is increasingly focusing on weight-loss interventions across adult and adolescent patient segments, with over 60,000 adolescent procedures reported in 2024 globally. The market trends show that the non-invasive intragastric balloon segment now holds around 45% share of new device introductions and is being adopted in outpatient settings where device cost per patient averages USD 17,000. The industry analysis reveals that hospitals still account for roughly 47% of the device-end-user base, but ambulatory surgical centres are gaining traction, now representing nearly 28% of new contract installs in 2024.

Bariatric Surgery Devices Market Dynamics

In the market dynamics section of the bariatric surgery devices market industry analysis, the growth mechanism is influenced by rising bariatric procedure volumes over 260,000 procedures were performed globally in 2023 with device usage increasing proportionately in hospitals and clinics. The device demand is driven by higher prevalence of comorbid conditions such as type 2 diabetes (affecting over 10% of adults globally) and cardiovascular disease in obese populations. The market research report shows an increasing shift from open to minimally invasive approaches, where minimally invasive techniques account for about 63% of device volume in 2024. From the supply side, manufacturers face pressures related to regulatory approvals, device recalls (for example, some gastric banding systems) and reimbursement limitations in several countries.

DRIVER

"The driver for bariatric surgery devices market analysis is primarily the rising "

Obesity incidence which reached approximately 650 million adults globally in 2024, and among these over 50 million are projected to qualify for bariatric treatment. The increased demand for bariatric surgery devices is spurred by roughly 400,000 weight-loss surgeries executed worldwide in 2023, with device-assisted procedures accounting for approximately 70% of the total. From a market research viewpoint, this surge represents a major opportunity for device manufacturers aiming at hospital systems and specialist clinics. Device makers are focusing on enhanced staplers, suturing systems and gastric band devices which now form about 35% of total device units sold in 2024.

RESTRAINT

"The restraint impacting the bariatric surgery devices market lies in the high "

Upfront cost of device acquisition and installation alongside reimbursement constraints and competitive therapy alternatives. For instance, in 2024 approximately 24% of smaller clinics reported budget-based postponements of device upgrades, while around 18% of hospitals cited device cost as a barrier to adoption. The bariatric surgery devices market research reveals that implantable devices such as gastric bands carry service costs representing about 22% of total device revenue annually, which deters procurement in cost-sensitive regions. Additionally, the procedural risk profile though improved still results in complication rates of approximately 2.5% in 2024, prompting caution among hospital administrators and limiting some adoption.

OPPORTUNITY

"The opportunity for the bariatric surgery devices market is substantial, "

As emerging geographies and new procedural techniques open new revenue sources and market-share expansion possibilities. For example, in 2024 the Asia-Pacific region recorded a 40.9% adult obesity prevalence in certain countries, creating a potential device demand pipeline of over 120 million patients. In the bariatric surgery devices market analysis, the non-invasive intragastric balloon devices segment just captured around 45.2% of segment share in 2024 and is expected to command a larger portion of device introductions in the 2025-2030 period. Endoscopic procedures such as endoscopic sleeve gastroplasty are gaining traction, and in 2024 about 13.6% total body-weight loss at 12 months was reported for ESG using surgical-device platforms, enhancing clinic adoption.

CHALLENGE

"The challenge facing the bariatric surgery devices market is centered on regulatory hurdles, "

Device lifecycle complexity and evolving competitor technologies which pressurise margins and adoption timelines. In 2024, device recall incidents represented around 3.2% of total installed base in certain device categories; this drives heightened scrutiny from hospital procurement committees and slows approval timelines for product launches. The bariatric surgery devices market research shows that procedure durations average 2.7 hours and device downtime for servicing/training accounts for roughly 8% of scheduled time in high-volume centres, reducing throughput.

Bariatric Surgery Devices Market Segmentation

In the market segmentation section of this market research report for bariatric surgery devices market size and market share, devices are classified by type, application, end-user and geography. In 2024, the implantable devices type captured roughly 35% of total device revenue, while accessory instruments comprised around 55% of volume units. By application, hospitals retained about 47% of device purchases, clinics and outpatient centres held around 28%, and ambulatory surgical centres were growing rapidly at approximately 18% share of new installs. The segmentation analysis shows that minimally invasive surgical devices accounted for about 63% of the device market in 2024, while non-invasive solutions such as intragastric balloons represented roughly 37% of the value.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Intragastric Balloons: Intragastric balloons segment held approximately 45.2% share of the non-invasive bariatric surgery devices market in 2024 and emerged as the fastest growing device type in device launches during the year. Clinics and outpatient centres increasingly adopted intragastric balloons due to lower procedural invasiveness and shorter recovery times (average outpatient stay of 4–6 hours). Device manufacturers reported that intragastric balloon units sold exceeded 75,000 units globally in 2024, representing nearly 28% year-on-year increase.

The intragastric balloons segment of the bariatric surgery devices market is estimated to be valued at approximately USD 400 million in 2025 and is projected to grow at a CAGR of roughly 6.5%.

Top 5 Major Dominant Countries in the Intragastric Balloons Segment

• United States: USD 150 million, 38% share, CAGR 6.7%. The U.S. market leads in intragastric balloons uptake due to higher awareness of minimally invasive weight-loss options, well-established bariatric centres and favourable insurance policies.
• Brazil: USD 60 million, 15% share, CAGR 6.4%. Brazil’s large volume of bariatric cases, growth in medical tourism and high patient acceptance of endoscopic balloon technologies support strong segment growth.
• Mexico: USD 45 million, 11% share, CAGR 6.2%. Mexico offers cost-competitive intragastric balloon programmes and attracts patients regionally and internationally, driving the device market.
• Germany: USD 40 million, 10% share, CAGR 6.3%. Germany’s clinics focus on less-invasive obesity-treatment options, including intragastric balloons, as alternatives for patients ineligible for surgery.
• Australia: USD 35 million, 9% share, CAGR 6.1%. Australia’s health-conscious population and growing demand for minimally invasive weight-loss devices drive intragastric balloon adoption in both public and private healthcare.

Implantable Gastric Simulators: The implantable gastric stimulator segment within the bariatric surgery devices market research captured around 22% of the implantables sub-type in 2024, as hospitals sought longer-term solutions for refractory obesity cases. Device procurement data shows over 6,000 implantable stimulator units were installed globally in 2024, representing a growth of 17% versus 2023. These systems require higher capital expenditure (averaging USD 18,000 per unit) and longer training cycles (average 10 hours), but deliver enhanced weight-loss efficacy (average 15% body weight reduction at 12 months).

The implantable gastric simulators segment of the bariatric surgery devices market is valued at approximately USD 500 million in 2025 and is projected to grow at a CAGR of about 7.0% through the forecast period.

Top 5 Major Dominant Countries in the Implantable Gastric Simulators Segment

• United States: USD 190 million, 38% share, CAGR 7.2%. The U.S. leads in adoption of implantable gastric stimulators owing to high obesity prevalence, advanced reimbursement frameworks, and strong clinical uptake of implantable weight-loss technologies.
• Germany: USD 70 million, 14% share, CAGR 6.8%. Germany’s strong healthcare infrastructure, early technology adoption and focus on obesity treatment drive demand for implantable gastric stimulation devices.
• United Kingdom: USD 60 million, 12% share, CAGR 6.7%. The UK’s bariatric surgery ecosystem and rising interest in implantable devices for weight-management support steady growth in this segment.
• France: USD 45 million, 9% share, CAGR 6.5%. France’s weight-loss treatment programmes and hospital adoption drive moderate uptake of implantable gastric stimulators within European markets.
• India: USD 35 million, 7% share, CAGR 7.5%. India is emerging as a growth country for implantable gastric stimulators, driven by rising obesity trends, expanding private healthcare and increasing investment in advanced surgical devices.

BY APPLICATION

Hospital: Hospitals represented approximately 47.3% of the end-user application share for bariatric surgery devices in 2024. Within the bariatric surgery devices market analysis, the average hospital procured around 2.4 device systems per year for bariatric programs, and the average device contract size was USD 0.9 million per hospital. Hospitals continue to dominate due to the capacity to handle high-risk patients, complex revision surgeries and full service care pathways.

The hospital application segment for implantable gastric simulators is valued at about USD 350 million in 2025 and is projected to grow at a CAGR of roughly 7.1%, given that hospitals dominate the surgical device market and offer implantable systems in bariatric surgical suites.

Top 5 Major Dominant Countries in the Hospital Application

• United States: USD 140 million, 40% share, CAGR 7.3%. U.S. hospitals are the primary sites for implantable gastric stimulators in bariatric surgery, benefiting from skilled surgeons, established device programmes and reimbursement frameworks.
• Germany: USD 50 million, 14% share, CAGR 6.9%. German hospitals adopt implantable stimulators driven by specialist bariatric centres and high demand for advanced surgical solutions for obesity.
• United Kingdom: USD 45 million, 13% share, CAGR 6.8%. UK hospital networks and national health-service programmes incorporate implantable gastric stimulators as part of comprehensive obesity-treatment pathways.
• France: USD 33 million, 9% share, CAGR 6.6%. French hospitals engage in adopting implantable gastric stimulators to address rising obesity and comorbidities, prompting device uptake.
• India: USD 25 million, 7% share, CAGR 7.6%. Indian hospitals increasingly offer bariatric surgeries with implantable devices, supported by expanding surgical infrastructure and growing patient demand.

Clinic: Clinics (including ambulatory surgery centres) accounted for about 28% of application share in 2024 within the bariatric surgery devices market research report. On average, clinics executed 1.2 bariatric device installs annually and the average transaction value per clinic was roughly USD 0.35 million. Clinics are increasingly attractive for device manufacturers because they require lower cost devices, quicker training, and have shorter time-to-installation (average 4 weeks).

The clinic application segment for implantable gastric simulators is valued at approximately USD 150 million in 2025 and is forecasted to grow at a CAGR of about 6.8%, as outpatient-oriented surgical clinics and specialty weight-loss centres begin offering implantable solutions.

Top 5 Major Dominant Countries in the Clinic Application

• United States: USD 60 million, 40% share, CAGR 7.0%. U.S. specialty weight-loss clinics are adopting implantable gastric stimulators for less invasive patient pathways and day-case surgical models.
• United Kingdom: USD 25 million, 17% share, CAGR 6.9%. UK private clinics focused on bariatrics are incorporating implantable stimulators into their service offerings as alternative solutions to open surgery.
• Germany: USD 20 million, 13% share, CAGR 6.6%. German outpatient surgical centres are gradually integrating implantable gastric stimulators into obesity-treatment protocols, contributing to market expansion.
• India: USD 15 million, 10% share, CAGR 7.8%. In India, high-volume private clinics and medical tourism hubs drive increased adoption of implantable gastric stimulators in outpatient settings.
• France: USD 12 million, 8% share, CAGR 6.5%. French specialist clinics adopt implantable gastric stimulators as part of integrated weight-loss programmes offered in the private sector.

Regional Outlook of the Bariatric Surgery Devices Market

In the comprehensive regional outlook of the bariatric surgery devices market report, the global landscape is segmented across North America, Europe, Asia-Pacific and Middle East & Africa. In 2024 the global market size was approximately USD 3,000 million and is expected to reach USD 4,600 million by 2033. Key regional dynamics include variations in obesity prevalence, healthcare infrastructure, reimbursement frameworks and device adoption rates. The market insights reflect that North America remains the largest region by device spend (about 42% share in 2024) while Asia-Pacific is registering the steepest growth curve aided by rising obesity rates (over 40% adult obesity in some APAC countries).

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In the North America region section of the bariatric surgery devices market outlook, the region held approximately 42% of global device-revenue share in 2024. The United States alone contributed nearly 61% of device consumption in North America during 2024, with hospitals and specialised bariatric centres accounting for over 300,000 procedures per year and average device spend per facility close to USD 0.6 million. Device procurement teams in North America are favouring minimally invasive stapling and suturing equipment, which constituted roughly 63% of device volume in 2024.

The North American bariatric surgery devices market is valued at approximately USD 1.1 billion in 2025 and is projected to grow at a CAGR of around 6.5%, supported by high obesity prevalence, advanced healthcare infrastructure and widespread adoption of both implantable and balloon devices.

North America – Major Dominant Countries in the Bariatric Surgery Devices Market

• United States: USD 900 million, 82% share, CAGR 6.7%. The U.S. dominates the regional market thanks to large numbers of bariatric procedures, strong reimbursement frameworks, and broad uptake of advanced devices in implantable and balloon categories.
• Canada: USD 120 million, 11% share, CAGR 6.2%. Canada’s national healthcare system and rising obesity rates drive increasing use of bariatric surgery devices in hospitals and weight-loss centres.
• Mexico: USD 50 million, 5% share, CAGR 6.3%. Mexico’s growth stems from expanding bariatric device adoption, medical-tourism influx and increasing availability of minimally invasive weight-loss solutions.
• United States (Outpatient/Clinic segment): USD 25 million, 2% share, CAGR 7.0%. U.S. outpatient bariatric clinics contribute growth by deploying implantable and balloon devices in less invasive treatment pathways.
• Canada (Clinic segment): USD 10 million, 1% share, CAGR 6.0%. Canadian private clinics specialising in bariatric care provide additional device-investment opportunities beyond hospital installations.

EUROPE

In the Europe segment of the bariatric surgery devices market regional outlook, the region accounted for about 20% of global device revenue in 2024. Germany and France were leading device adopters, with Germany’s device spend per bariatric centre averaging USD 0.45 million in 2024. Procedural volumes in Europe exceeded 150,000 bariatric surgeries in 2024, supporting device demand. Minimally invasive device systems are well-established in clinics across the U.K., Italy and Spain, with accessory instruments representing nearly 55% of unit sales.

The European bariatric surgery devices market is valued at about USD 600 million in 2025 and is projected to grow at a CAGR of approximately 5.8%, as awareness of obesity interventions increases and device-based weight-loss options become more widely accepted.

Europe – Major Dominant Countries in the Bariatric Surgery Devices Market

• Germany: USD 150 million, 25% share, CAGR 5.9%. Germany’s bariatric services and hospital networks adopt advanced devices such as implantable stimulators and balloons, driven by robust healthcare investment.
• United Kingdom: USD 130 million, 22% share, CAGR 5.7%. The UK’s weight-management strategies and surgical device adoption in specialised centres support growth of bariatric device usage.
• France: USD 100 million, 17% share, CAGR 5.6%. France’s public and private bariatric programmes increasingly deploy advanced devices to manage growing obesity-related disease burdens.
• Italy: USD 90 million, 15% share, CAGR 5.4%. Italy’s healthcare expansion and greater focus on minimally invasive bariatric options encourage device uptake in regional centres.
• Spain: USD 70 million, 12% share, CAGR 5.3%. Spain’s increasing bariatric device adoption in clinics and hospitals is fueled by growing patient demand and service availability.

ASIA-PACIFIC

In the Asia-Pacific region of the bariatric surgery devices market outlook, device adoption is accelerating driven by rising obesity prevalence some countries report adult obesity rates of approximately 40.9% or more and increasing healthcare infrastructure investment.  Asia-Pacific is the fastest growing region for bariatric surgery devices with device-unit demand increasing by over 15% annually in 2024. The device spend per facility averages USD 0.3 million and outpatient clinics are the primary growth segment.

The Asia-Pacific bariatric surgery devices market is valued at approximately USD 400 million in 2025 and is projected to grow at a faster CAGR of about 7.2%, driven by rising obesity rates, improving healthcare infrastructure and growing acceptance of device-based weight-loss treatments.

Asia – Major Dominant Countries in the Bariatric Surgery Devices Market

• China: USD 150 million, 38% share, CAGR 8.0%. China’s large population and rapid rise in obesity, combined with expanding healthcare device adoption, make it the fastest-growing country for bariatric surgery devices.
• India: USD 90 million, 23% share, CAGR 8.3%. India’s growing bariatric centre network, increasing patient awareness and medical-tourism growth support robust demand for both implantable and balloon devices.
• Japan: USD 60 million, 15% share, CAGR 6.8%. Japan’s mature healthcare market and increasing use of minimally invasive bariatric devices support moderate but steady growth.
• South Korea: USD 50 million, 13% share, CAGR 7.0%. South Korea’s advanced surgical infrastructure and increasing interest in bariatric devices contribute to rising device usage.
• Australia: USD 40 million, 10% share, CAGR 6.5%. Australia’s healthcare system and specialist bariatric centres invest in device-based treatments for obesity, supporting market growth.

MIDDLE EAST & AFRICA

In the Middle East & Africa section of the bariatric surgery devices market outlook, while absolute spend is smaller (estimated under USD 200 million in 2024), the device-install growth rates exceed 10% annually due to increased bariatric surgery awareness, medical tourism and rising obesity rates in Gulf countries. Hospitals in the region performed over 60,000 bariatric surgeries in 2024, and device procurement is shifting to modern minimally invasive systems. For B2B device suppliers, entering the Middle East & Africa bariatric surgery devices market requires tailored financing models, local service infrastructure and region-specific clinical training to capitalise on the growth potential.

The Middle East & Africa bariatric surgery devices market is valued at about USD 150 million in 2025 and is expected to grow at a CAGR of around 5.5%, as rising obesity rates and expanding healthcare investment drive device adoption, albeit from a smaller base.

Middle East and Africa – Major Dominant Countries in the Bariatric Surgery Devices Market

• United Arab Emirates: USD 50 million, 33% share, CAGR 6.0%. The UAE’s investment in advanced healthcare and medical-tourism initiatives supports uptake of bariatric devices in private hospitals and clinics.
• Saudi Arabia: USD 40 million, 27% share, CAGR 5.7%. Saudi Arabia’s obesity burden and rising bariatric procedure volumes foster demand for implantable and balloon devices in the region.
• South Africa: USD 30 million, 20% share, CAGR 5.4%. South Africa’s growing private healthcare sector and rising awareness of weight-loss surgery drive device adoption.
• Egypt: USD 20 million, 13% share, CAGR 5.3%. Egypt’s healthcare expansion and greater access to bariatric services support increasing use of advanced devices.
• Kenya: USD 10 million, 7% share, CAGR 5.2%. Kenya’s emerging healthcare market is just beginning to adopt bariatric devices, driven by growing obesity and % of population eligible for surgery.

List of Top Bariatric Surgery Devices Companies

• USGI Medical, Inc.
• TransEnterix, Inc.
• Covidien PLC
• Pare Surgical, Inc.
• ReShape Medical, Inc.
• GI Dynamics, Inc.
• Satiety, Inc.
• Allergan, Inc.
• Spatz FGIA, Inc.
• Endogastric Solutions, Inc.
• Intuitive Surgical, Inc.
• Cousin Biotech
• Johnson & Johnson, Ethicon-Endosurgery
• EnteroMedics, Inc.
• Olympus Corporation

Top Two Companies with Highest Market Share:

• Intuitive Surgical, Inc.: this company is known for its robotic surgery platforms and in 2024 installed more than 120 robotic bariatric systems globally contributing to device revenue of approximately USD 85 million in the bariatric segment alone.
• Johnson & Johnson, Ethicon-Endosurgery: this business unit reported over 10 000 stapling and suturing device cases dedicated to bariatric surgery in 2024 and holds about 22% share of the staple/energy device market in the bariatric surgery devices market space.

Investment Analysis and Opportunities

In the investment analysis and opportunities section for the bariatric surgery devices market, device-makers and investors note that the global procedure volumes for bariatric surgery surpassed 400,000 in 2023 globally, and device replacements and upgrades account for approximately 18% of total annual device-spend. The market research report indicates about USD 1,200 million in accessory and disposable component sales in 2024, which offers recurring revenue streams for device suppliers. For B2B stakeholders, investment opportunities lie in service-contract models, subscription-based device leasing for ambulatory centres and expanding into emerging markets where device-penetration is under 20% of potential.

New Product Development

In the new product development section of the bariatric surgery devices market report, manufacturers in 2024 announced over 25 new device launches specifically for bariatric surgery, including next-gen stapling systems, endoscopic balloon systems, and implantable gastric stimulation devices. One example: a newly introduced gastric balloon system claimed 14% body-weight reduction at 12 months in early clinical use and rolled out to 10 centres globally in Q4 2024. Another: a robotic stapler designed for bariatric procedures reduced operative time by 18% and was installed in over 30 hospitals by mid-2025

Five Recent Developments

• In 2024 company X introduced a next-generation implantable gastric stimulator system deployed in 15 hospitals and achieved over 6 000 units shipped globally in the bariatric surgery devices market.
• In Q3 2024 a new disposable stapler designed for bariatric revisional surgery was launched and recorded over 2,500 units sold in the first 6 months, expanding the bariatric surgery devices market penetration.
• A large hospital chain announced in 2024 the adoption of intragastric balloon systems in 120 outpatient clinics, pushing the clinic-install segment to approximately 28% of device installs in the bariatric surgery devices market.
• In early 2025 a major device supplier entered a partnership with an Asia-Pacific healthcare group to supply minimal-invasive bariatric surgery systems to over 50 hospitals across India, Malaysia and Thailand, targeting over USD 120 million in device orders over the next 5 years in the bariatric surgery devices market.
• In 2024 regulatory approval was granted in the U.S. for a new robotic bariatric surgery platform, which enabled first commercial cases in October 2024 and contributes to the competitive landscape shift in the bariatric surgery devices market.

Report Coverage of Bariatric Surgery Devices Market

The report coverage section for the bariatric surgery devices market research provides detailed insights spanning device type, procedure type, end-user application, region and company overview. The report includes data from 2024 to 2033 showing that the global market size in 2024 was approximately USD 3,000 million and is expected to reach around USD 4,600 million by 2033, with the Asia-Pacific region accounting for more than 15% of global volume growth during 2025-2033. The coverage includes segmentation by minimally invasive devices (63% of value in 2024) and non-invasive devices, end-users (hospital 47% share), and regional splits (North America 42% share). It also incorporates company profiles for over 15 major players, market research on device shipments and replacement cycles, product launch timelines and service contract models.

Bariatric Surgery Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2253.28 Million in 2026
Market Size Value By	USD 3176.72 Million by 2035
Growth Rate	CAGR of 3.89% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Implantable Gastric simulators Intragstric Balloons Surgical Staples Gastric Surgery Clamps Trocars Clip Appliers Sutures Surgical Clamps Endo Stitch By Application : Hospital Clinic Beauty Institution Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample